Particle.news

Download on the App Store

Advocate Health Stops Prescribing Gender Care Medications to Patients Under 19

Federal funding pressure plus DOJ subpoenas prompted the policy change.

Overview

  • Advocate Health confirmed it revised its policy to end prescriptions of puberty blockers and hormone therapies for patients younger than 19.
  • The system operates 69 hospitals across six states, including 11 hospitals and 200 care sites in Illinois, making the shift significant for statewide access.
  • Advocate said it is contacting affected families and has set up a hotline to offer counseling and guidance related to the change.
  • The move follows a regional pullback, with UChicago Medicine discontinuing all pediatric gender care and Rush, UI Health, and Lurie Children’s scaling back surgeries or medications for minors.
  • The cutbacks track federal actions, including President Trump’s executive order threatening research and Medicare/Medicaid funding and more than 20 DOJ subpoenas, one seeking patient identifiers from Children’s Hospital of Philadelphia; Illinois and 15 other states filed suit on Aug. 1 challenging the directives.